NetworkNewsBreaks

WednesdayJan 05, 2022 1:06 pm

NetworkNewsBreaks – Revelstone Capital Acquisition Corp. (NASDAQ: RCACU) Closes $150M IPO

Revelstone Capital (NASDAQ: RCACU) has closed its initial public offering of 15,000,000 units, each at a price of $10.00. The units began trading on the Nasdaq Global Market under the ticker symbol RCACU on Dec. 17, 2021. According to the update, each unit consists of one share of Class A common stock and one-half of one redeemable warrant, with each whole warrant entitling the holder to purchase one share of common stock, each at a price of $11.50. Once the securities comprising the units begin separate trading, the common stock and warrants are expected to be listed on the Nasdaq…

Continue Reading

WednesdayJan 05, 2022 12:48 pm

NetworkNewsBreaks – The Honeybee Collective Breaks Record to Raise $107K in First Funding Round

The Honeybee Collective, an employee-owned, community-driven, sustainable cannabis startup launching in February 2022, today announced that it raised $107,000, a first-round maximum, in just four days. According to the update, the campaign broke crowdfunding platform Mainvest's 48-hour funding record, raising $80,000. The company’s campaign will reopen on Jan. 10, 2022, with a $250,000 overall fundraising goal. “We knew our community would support The Honeybee Collective’s mission because we built our brand in direct conversation with them, but we never could have predicted how that support would translate into dollars so quickly,” said Erin Parkins, co-founder and managing partner, Marketing and…

Continue Reading

WednesdayJan 05, 2022 12:32 pm

NetworkNewsBreaks – LQwD Fintech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Releases Corporate and Operational Update

LQwD Fintech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network, today provided a corporate re-cap. The update noted several milestones since the company completed the acquisition of LQwD Financial Corp. in June 2021, creating the first publicly traded Lightning Network company. “I wanted to take a moment to re-cap what has been an active six months for LQwD since listing in June,” said CEO Shone Anstey in the news release. “The remarkable growth of the Lightning Network has validated LQwD's reason to be hyper-focused on Lightning, and I look…

Continue Reading

WednesdayJan 05, 2022 12:21 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Releases Dates for 2022 Virtual Conferences

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, has scheduled several industry-specific events for 2022. The company has announced its initial schedule for 2022 conferences. The company will hold its first event — the Sequire Metals & Mining Conference — on Jan. 27, 2022; the event is slated to run from 9 a.m. to 5 p.m. ET. In making the announcement, SRAX noted that it has expanded the event to a full day based on significant increase in interest and activity in the mining and electric…

Continue Reading

WednesdayJan 05, 2022 12:01 pm

NetworkNewsBreaks – Friendable Inc. (FDBL) Issues 2021 Milestones, 2022 Strategy

Friendable (OTC: FDBL), a mobile technology and marketing company, has announced the expansion of service offerings available on its Fan Pass Live artist platform; those services include different options for music distribution and indie artist tools. The announcement was made as the company provided an update on and timeline for key milestones and achievements reached in 2021. That timeline included release of the Fan Pass platform in April 2020 and ending with the announcement that FDBL had signed a material agreement in December 2021 outlining the acquisition of Artist Republik, which includes artists, music distribution technology and services alongside various other…

Continue Reading

WednesdayJan 05, 2022 11:38 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Annual Shareholder Letter Provides Company Highlights, 2022 Outlook

InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, has released a shareholder letter. The letter, from president and CEO Eric A. Adams, provided INM shareholders with a company update, including a look at key milestones the company had reached, including the acquisition of BayMedica, which Adams said positioned InMed as a clear leader in rare cannabinoid manufacturing. Adams also noted that the company continued to make significant strides with its proprietary IntegraSyn(TM) program and is advancing its pharmaceutical programs, thanks in large part to the library of novel cannabinoid analogs developed by BayMedica.…

Continue Reading

WednesdayJan 05, 2022 10:52 am

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces January 2022 Health Care Conference Schedule

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced that it will present next week at the H.C. Wainwright Bioconnect Conference and the Biotech Showcase. The events are slated to be held virtually on Jan. 10-12, 2022. Tryp’s CEO and Chairman Greg McKee will provide an overview of the company and updates on its chronic pain and eating disorder programs. This year, all corporate presentations will be pre-recorded and available on-demand for registered attendees. In addition, replays of the presentations will be available on the Events section…

Continue Reading

TuesdayJan 04, 2022 3:26 pm

NetworkNewsBreaks – Bassett Furniture Industries, Inc. (NASDAQ: BSET) Featured in Research Note from Sidoti

Earnings Preview; Estimates Lowered Bassett Furniture Industries (NASDAQ: BSET) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “Supply Chain Issues, Higher Costs Likely Hurt 4Q:F21; Favorable Demand, Potential Supply Chain Normalization May Enable F2022, F2023 EPS Gains; Maintain Moderately Risky Rating, $36 Target.” Click here to access the full report. About Bassett Furniture Industries, Inc. Bassett Furniture Industries is a leading manufacturer and marketer of high-quality home furnishings. With 97 company and licensee-owned stores at the time of this release, Bassett has leveraged its strong brand name in furniture into…

Continue Reading

TuesdayJan 04, 2022 2:26 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Improving Bioavailability of Pharmaceuticals One Drug Class at a Time

As a significant number of drugs fail to reach the market owing to poor bioavailability, Lexaria Bioscience Corp. (NASDAQ: LEXX) is among those companies exploring different tools and methods to try to solve the problem. Lexaria is currently leading the industry in terms of innovation in drug delivery platforms. “Its patented DehydraTECH(TM) technology is specifically designed to improve how active pharmaceutical ingredients (‘APIs’) enter the bloodstream, ultimately increasing the effectiveness of fat-soluble molecules,” reads a recent article. The piece discusses Lexaria’s DehydraTECH as a product of years of research and millions in investments. Currently, the technology is covered by 23…

Continue Reading

TuesdayJan 04, 2022 2:02 pm

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Support Low-Cost/No-Cost Psychedelic Clinic for Underserved Communities

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is marking key milestones to revolutionize mental health care. Among these, the company recently secured a grant for the first-ever psychedelic treatment clinic at Lenox Hill Hospital. The hospital is part of Northwell Health, the largest health care system in New York State, and serves marginalized communities on the Upper East Side of Manhattan. Lenox Hill is working to become one of the first hospital-based clinical sites to offer psychedelic medicine in the United States. A recent article quotes Cybin Chief Clinical Officer Dr. Alex…

Continue Reading